Try
Glaukos Corporation Common Stock
GKOSUnited States
68 filed reports · 517 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
68 reports · Jun 2015 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 50 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 34 | 5,838 | Jun 2015 to Jun 2026 |
| Current · 8-KSEC EDGAR | 23 | 48 | Sep 2015 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 11 | 5,219 | Dec 2015 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 29, 2026 | 2 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 29, 2026 | 420 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | Apr 30, 2026 | 267 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 23, 2026 | 961 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 31, 2025 | 298 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 4, 2025 | 189 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 1, 2025 | 189 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 25, 2025 | 444 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 5, 2024 | 181 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 2, 2024 | 170 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 3, 2024 | 168 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 23, 2024 | 430 | Open |
Financial data
517 concepts · 11,105 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial495 concepts · 10,411 facts · Dec 2013 to Jul 2026
- Gross profit (US GAAP)63 · Dec 2013 to Jun 2026
- Net income loss63 · Dec 2013 to Jun 2026
- Operating expenses (US GAAP)63 · Dec 2013 to Jun 2026
- Operating income loss63 · Dec 2013 to Jun 2026
- Profit loss63 · Dec 2013 to Jun 2026
- Revenue63 · Dec 2013 to Jun 2026
- Selling general and administrative expense63 · Dec 2013 to Jun 2026
- Allocated share based compensation expense62 · Dec 2013 to Jun 2026
- Comprehensive income net of tax62 · Dec 2013 to Jun 2026
- Nonoperating income expense62 · Dec 2013 to Jun 2026
- Other comprehensive income loss foreign currency transaction and translation adjustment net of tax62 · Dec 2013 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities61 · Dec 2013 to Jun 2026
- Increase decrease in accounts receivable61 · Dec 2013 to Jun 2026
- Increase decrease in inventories61 · Dec 2013 to Jun 2026
- Other comprehensive income loss net of tax61 · Dec 2013 to Jun 2026
- Prepaid expenses and other current assets61 · Dec 2013 to Jun 2026
- Proceeds from stock options exercised61 · Dec 2013 to Jun 2026
- Share based compensation61 · Dec 2013 to Jun 2026
- Cash and cash equivalents at carrying value60 · Dec 2013 to Jun 2026
- Income tax expense benefit60 · Dec 2013 to Jun 2026
- Property plant and equipment net60 · Dec 2013 to Jun 2026
- Total accrued liabilities60 · Dec 2014 to Jun 2026
- Increase decrease in other noncurrent assets59 · Dec 2013 to Jun 2026
- Payments to acquire property plant and equipment59 · Dec 2013 to Jun 2026
Geography4 concepts · 270 facts · Dec 2013 to Jun 2026
- Revenue134 · Dec 2013 to Jun 2026
- Depreciation depletion and amortization50 · Dec 2013 to Jun 2026
- United States48 · Dec 2013 to Jun 2026
- Property, Plant & Equipment, Net38 · Dec 2014 to Jun 2026
Product1 concepts · 206 facts · Dec 2017 to Jun 2026
- Revenue206 · Dec 2017 to Jun 2026
Segment15 concepts · 170 facts · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- Development and Commercialization of Ophthalmic Therapies14 · Dec 2022 to Jun 2026
- General and administrative expense (US GAAP)14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Interest and other income14 · Dec 2022 to Jun 2026
- Interest expense nonoperating14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Other expense, net14 · Dec 2022 to Jun 2026
- Research and development expense14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Selling and marketing expense (US GAAP)14 · Dec 2022 to Jun 2026
- Acquired in-process research and development8 · Dec 2022 to Dec 2025
- Induced conversion of convertible debt expense6 · Dec 2023 to Dec 2025
- Gain loss related to litigation settlement1 · Dec 2022
- Impairment of intangible asset1 · Dec 2025
Guidance2 concepts · 48 facts · Nov 2015 to Jul 2026
- Revenue Guidance44 · Nov 2015 to Jul 2026
- Revenue Growth Guidance4 · Jan 2016 to Feb 2021
Segments
646 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service2 members · 206 facts
- Glaucoma107 · Dec 2017 to Jun 2026
- Corneal Health99 · Dec 2019 to Jun 2026
Statement geographicalsrt:StatementGeographicalAxis4 members · 180 facts
- US84 · Dec 2016 to Jun 2026
- Non Us82 · Dec 2016 to Jun 2026
- Us7 · Dec 2024 to Jun 2026
- Non us7 · Dec 2024 to Jun 2026
Statement business segments1 member · 170 facts
- Development And Commercialization Of Ophthalmic Therapies170 · Dec 2022 to Jun 2026
Statement geographicalus-gaap:StatementGeographicalAxis4 members · 90 facts
- Non Us33 · Dec 2013 to Sep 2018
- US33 · Dec 2013 to Sep 2018
- Us12 · Dec 2014 to Dec 2025
- Non us12 · Dec 2014 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary50 claims from 9 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary161 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes13 claims from 1 reports · Dec 2025
- Risk factors63 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 29, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.